Results 1 to 10 of about 8,740 (131)

Long-term outcomes of haploidentical hematopoietic stem cell transplantation with antithymocyte globulin-based myeloablative conditioning in pediatric refractory or relapsed non-Hodgkin lymphoma. [PDF]

Pediatr Investig
Single‐center retrospective data showed that ATG‐based myeloablative haploidentical hematopoietic stem cell transplantation provides durable remission and favorable long‐term survival in children with refractory/relapsed non‐Hodgkin lymphoma, achieving high engraftment rates, low relapse incidence, and acceptable toxicity.
Jia C, Zheng J, Yuan M, He H, Fan Y, Wang B, Zhu G, Yang J, Luo Y, Cai L, Zhang P, Duan Y, Qin M.   +12 more
europepmc   +2 more sources

Rabbit-Derived Antithymocyte Globulin-Associated Perioperative Anaphylaxis in Renal Transplantation: A Multidisciplinary Perspective on Pathophysiology, Clinical Presentation, and Management [PDF]

Antibodies
Rabbit antithymocyte globulin is one of the most commonly used agents for induction immunosuppression in renal transplantation. It has contributed significantly to improved allograft survival and has a favorable safety profile.
Imran Gani, Usman Baig, Ahmad Mirza, Shais Jallu, Abrar Ahad Chawdhary   +4 more
doaj   +2 more sources

Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant Patients [PDF]

Transplantation Direct, 2022
Background. The dosing intensity of antithymocyte globulin as induction therapy in heart transplantation remains controversial. We sought to evaluate the efficacy and safety of rabbit antithymocyte globulin at a total dose of 4.5 mg/kg compared with
Grace Pui-Yun Lee, PharmD, BCCCP, Richard K. Cheng, MD, MSc, Alexi Vasbinder, PhD, RN, Sixuan Wu, MSc, Beatrice Wong, PharmD, Stephen D. Farris, MD, Daniel Fishbein, MD, Jenny Man-Ching Wong, PharmD, BCPS   +7 more
doaj   +2 more sources

Antithymocyte globulin therapy in chronic lung allograft dysfunction [PDF]

Frontiers in Transplantation
IntroductionLung transplantation has seen strides in survival over the past few decades, though long-term survival remains poor. Chronic lung allograft dysfunction (CLAD) is a leading cause of graft failure and mortality beyond the first year.
Akhilesh Ajay Padhye, Danielle Guffey, Andres Leon-Pena, Justin Segraves, Ramiro Fernandez, Gabriel Loor, Puneet Garcha, Tianshi David Wu, Gloria Li   +8 more
doaj   +2 more sources

Indigenous antithymocyte globulin-equine to treat aplastic anaemia in adults: a case series from two centres in northeast India [PDF]

Hematology, Transfusion and Cell Therapy
Background: Immunosuppressive therapy is the standard management of adults with aplastic anaemia. Antithymocyte globulin is used as first-line treatment of patients not eligible for bone marrow transplantation.
Asif Iqbal, Abhijit Phukan, Chandana Sharma   +2 more
doaj   +2 more sources

Successful desensitization to horse antithymocyte globulin for aplastic anemia: two case reports and literature review [PDF]

Journal of Pharmaceutical Health Care and Sciences
Background Horse antithymocyte globulin (hATG) is an important therapeutic option for aplastic anemia (AA). However, hATG carries the risk of fatal anaphylaxis, and skin tests are performed to identify high-risk patients.
Satoshi Yuyama, Mitsuaki Oura, Tatsuya Isezaki, Daisuke Ikeda, Kanayuki Kitahara, Ryohkan Funakoshi, Kosei Matsue   +6 more
doaj   +2 more sources

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A

Jornal de Pediatria (Versão em Português), 2014
Objective: To evaluate the outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine as first‐line treatment at this institution.
Marlene Pereira Garanito, Jorge David Aivazoglou Carneiro, Vicente Odone Filho, Phillip Scheinberg   +3 more
doaj   +3 more sources

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia

Haematologica, 2014
We recently reported that rabbit antithymocyte globulin was markedly inferior to horse antithymocyte globulin as a primary treatment for severe aplastic anemia. Here we expand on our findings in this unique cohort of patients.
Xingmin Feng, Phillip Scheinberg, Angelique Biancotto, Olga Rios, Sarah Donaldson, Colin Wu, Haiyun Zheng, Kazuya Sato, Danielle M. Townsley, J. Philip McCoy, Neal S. Young   +10 more
doaj   +1 more source